摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-Methanesulfonyl-naphthalen-1-ylamine | 1999-77-5

中文名称
——
中文别名
——
英文名称
5-Methanesulfonyl-naphthalen-1-ylamine
英文别名
Naphthalene, 1-amino-5-methylsulphonyl-;5-methylsulfonylnaphthalen-1-amine
5-Methanesulfonyl-naphthalen-1-ylamine化学式
CAS
1999-77-5
化学式
C11H11NO2S
mdl
——
分子量
221.28
InChiKey
CLIVBZOFLLDABH-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.9
  • 重原子数:
    15
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.09
  • 拓扑面积:
    68.5
  • 氢给体数:
    1
  • 氢受体数:
    3

文献信息

  • [EN] COMPOUNDS USEFUL IN THE TREATMENT OF NEOPLASTIC DISEASES<br/>[FR] COMPOSÉS UTILES DANS LE TRAITEMENT DE MALADIES NÉOPLASIQUES
    申请人:UNIVERSITÄT ZU KÖLN
    公开号:WO2015044177A1
    公开(公告)日:2015-04-02
    The present invention refers to compounds of formula: (formula A), wherein R1 is selected from (formula I), (formula II), (formula (III), (formula IV), (formula V), or (formula B), and wherein R2, R3, R4 and R5 are as defined in the claims and X is OTBS, hydroxy, formyloxy, acetoxy, nitrooxy, nitrooxymethyl, or a halogen; and pharmaceutically acceptable salts thereof, which are useful in the treatment of neoplastic or proliferative disorders, a pharmaceutical composition comprising such a compound and a method preparing this compound.
    本发明涉及以下式的化合物:(式A),其中R1从(式I),(式II),(式III),(式IV),(式V)或(式B)中选择,并且其中R2,R3,R4和R5如权利要求中定义的那样,X为OTBS,羟基,甲酰氧基,乙酰氧基,硝基氧基,硝基甲氧基或卤素;及其药学上可接受的盐,用于治疗肿瘤性或增生性疾病,包括这种化合物的药物组合物和制备该化合物的方法。
  • USE OF SUBSTITUTED SPIROCYCLIC SULFONAMIDOCARBOXYLIC ACIDS, CARBOXYLIC ESTERS THEREOF, CARBOXAMIDES THEREOF AND CARBONITRILES THEREOF OR SALTS THEREOF FOR ENHANCEMENT OF STRESS TOLERANCE IN PLANTS
    申请人:Frackenpohl Jens
    公开号:US20140038822A1
    公开(公告)日:2014-02-06
    Use of substituted spirocyclic sulfonamidocarboxylic acids, -carboxylic esters, -carboxamides and -carbonitriles or salts thereof for enhancement of stress tolerance in plants. The invention relates to the use of spirocyclic sulfonamidocarboxylic acids, -carboxylic esters, -carboxamides and -carbonitriles or salts thereof of the formula (I) in which the respective substituents have the meanings given in the description, for increasing stress tolerance in plants with respect to abiotic stress, and also for increasing plant growth and/or for increasing plant yield.
    使用取代的螺环磺酰胺羧酸羧酸酯、羧酰胺和羰基腈或其盐来增强植物的耐逆性。本发明涉及使用式(I)中的螺环磺酰胺羧酸羧酸酯、羧酰胺和羰基腈或其盐,其中各自的取代基在说明中给出,用于增强植物对非生物逆境的耐受性,以及增加植物生长和/或增加植物产量。
  • Compounds useful in the treatment of neoplastic diseases
    申请人:UNIVERSITÄT ZU KÖLN
    公开号:US10793509B2
    公开(公告)日:2020-10-06
    Compounds and pharmaceutically acceptable salts of the compounds are useful in the treatment of neoplastic diseases or proliferative disorders. The compounds are formulated into pharmaceutical compositions, which can be used in methods of treating neoplastic diseases or proliferative disorders The compounds are useful to treat cancers such as prostate, pancreatic, lung, skin, breast, bladder, colon, and blood cancers. The compounds are represented by the following formula:
    化合物及其药学上可接受的盐类可用于治疗肿瘤性疾病或增殖性疾病。 这些化合物可配制成药物组合物,用于治疗肿瘤性疾病或增殖性疾病。 这些化合物用下式表示:
  • COMPOUNDS USEFUL IN THE TREATMENT OF NEOPLASTIC DISEASES
    申请人:Universität zu Köln
    公开号:EP3049386B1
    公开(公告)日:2020-07-22
  • TRP INHIBITORS AND USES THEREOF
    申请人:Ostertag Eric M.
    公开号:US20120148604A1
    公开(公告)日:2012-06-14
    The present invention, relates to methods including compounds, derivatives, antibodies, interfering RNA, biologies, polypeptides, dominant negative effectors, and their use in the treatment of neuropathic pain by inhibition of transient receptor potential (TRP) channels. In another embodiment, this invention relates to inhibitors, antagonists, and agonists of TRPC4. TRPC4 therapeutic agents and modulators include but are not limited to small molecule inhibitors, compounds, amino acid derivatives, polypeptides, RNA interference agents, natural chemicals, ligand derivatives, and ions. TRPC4 therapeutic agents and modulators are developed for the treatment of neuropathic pain, including but not limited to pain sensations such as nociception, hyperalgesia, allodynia, and loss of sensory function.
查看更多